Literature DB >> 21365620

Turning conventional wisdom upside-down: low serum testosterone and high-risk prostate cancer.

Abraham Morgentaler.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21365620     DOI： 10.1002/cncr.25975

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

Review 1.  The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.

Authors:  William P Conners; Abraham Morgentaler
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

2.  Racial Differences in Age-Related Variations of Testosterone Levels Among US Males: Potential Implications for Prostate Cancer and Personalized Medication.

Authors:  Hui Hu; Folakemi T Odedina; Romonia R Reams; Claudia T K Lissaker; Xiaohui Xu
Journal:  J Racial Ethn Health Disparities       Date:  2014-09-11

3.  Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer.

Authors:  Huakang Tu; Jian Gu; Qing H Meng; Jeri Kim; Sara Strom; John W Davis; Yonggang He; Elizabeth A Wagar; Timothy C Thompson; Christopher J Logothetis; Xifeng Wu
Journal:  Oncol Lett       Date:  2017-01-18       Impact factor: 2.967

4.  Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States.

Authors:  Sarah S Jackson; Xuesong Han; Ziling Mao; Leticia Nogueira; Gita Suneja; Ahmedin Jemal; Meredith S Shiels
Journal:  J Natl Cancer Inst       Date:  2021-09-04       Impact factor: 11.816

5.  Red wine and component flavonoids inhibit UGT2B17 in vitro.

Authors:  Carl Jenkinson; Andrea Petroczi; Declan P Naughton
Journal:  Nutr J       Date:  2012-09-07       Impact factor: 3.271

Review 6.  Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model.

Authors:  Xiaohui Xu; Xinguang Chen; Hui Hu; Amy B Dailey; Brandie D Taylor
Journal:  BMC Cancer       Date:  2015-10-26       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.